Review: taking Miralax and Colace together


Summary

Drug interactions are reported among people who take Miralax and Colace together. This review analyzes the effectiveness and drug interactions between Miralax and Colace. It is created by eHealthMe based on reports of 2,133 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Miralax and Colace >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Miralax

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. (latest outcomes from Miralax 14,389 users)

Colace

Colace has active ingredients of docusate . It is often used in constipation. (latest outcomes from Colace 12,746 users)

On Aug, 21, 2016

2,133 people who take Miralax, Colace are studied.


Number of reports submitted per year:

Miralax and Colace drug interactions.

Drug effectiveness over time:

Miralax:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 3 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Colace:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 3 people)
  • 5 - 10 years: 33.0% - (1 of 3 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Miralax:
  • female: 25.0% - (2 of 8 people)
  • male: 14.0% - (1 of 7 people)
Colace:
  • female: 12.0% - (1 of 8 people)
  • male: 0.0% - (0 of 7 people)

Drug effectiveness by age:

Miralax:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 14.0% - (1 of 7 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 3 people)
Colace:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 14.0% - (1 of 7 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • dehydration
  • dizziness
  • febrile neutropenia
  • pericardial effusion
  • nausea
  • headache
  • cardiomegaly
  • contusion
  • hypoglycaemia
  • insomnia
1 - 6 months:
  • abdominal pain
  • headache
  • diarrhoea
  • dyskinesia
  • pneumonia fungal
  • arthralgia
  • blood glucose increased
  • fatigue
  • febrile neutropenia
  • influenza
6 - 12 months:
  • abdominal pain
  • anaemia
  • arthropathy
  • bronchitis
  • cellulitis
  • dizziness
  • dyspnoea
  • gastrointestinal haemorrhage
  • gastrooesophageal reflux disease
  • haematuria
1 - 2 years:
  • chest pain
  • confusional state
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fall
  • headache
  • inflammatory pain
  • insomnia related to another mental condition
  • loss of appetite
  • loss of control of legs
  • muscle contractions involuntary
2 - 5 years:
  • hallucination, auditory
  • nephrogenic systemic fibrosis
5 - 10 years:
  • abdominal pain
  • cardiac disorder
  • chest pain
  • deep vein thrombosis
  • dyspnoea
  • epistaxis
  • injury
  • nausea
  • oedema peripheral
  • pain
10+ years:
  • chest pain
  • confusional state
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fall
  • headache
  • inflammatory pain
  • insomnia related to another mental condition
  • loss of appetite
  • loss of control of legs
  • muscle contractions involuntary
not specified:
  • pain
  • nausea
  • dyspnoea
  • constipation
  • anxiety
  • fatigue
  • anaemia
  • back pain
  • fall
  • vomiting

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • dyspnoea
  • anxiety
  • fatigue
  • fall
  • anaemia
  • back pain
  • constipation
  • vomiting
male:
  • pain
  • constipation
  • fatigue
  • nausea
  • dyspnoea
  • anxiety
  • asthenia
  • vomiting
  • anaemia
  • diarrhoea

Most common drug interactions by age *:

0-1:
  • cerebral infarction
  • convulsion
  • encephalomalacia
  • hyperparathyroidism secondary
  • hypertension
  • infection
  • respiratory distress
  • therapeutic response decreased
  • transplant rejection
  • leukopenia
2-9:
  • epistaxis
  • decreased appetite
  • pyrexia
  • abdominal pain
  • lymphadenopathy
  • mucosal inflammation
  • weight decreased
  • aggression
  • alopecia
  • atelectasis
10-19:
  • hypertension
  • headache
  • pain
  • hypotension
  • nausea
  • vomiting
  • back pain
  • haematocrit decreased
  • alanine aminotransferase increased
  • abdominal pain
20-29:
  • nausea
  • pain
  • injury
  • abdominal pain
  • dyskinesia
  • chest pain
  • pulmonary embolism
  • febrile neutropenia
  • pneumonia fungal
  • anxiety
30-39:
  • nausea
  • pain
  • dyspnoea
  • fatigue
  • pneumonia
  • paraesthesia
  • pain in extremity
  • injury
  • oedema peripheral
  • abdominal pain
40-49:
  • pain
  • anxiety
  • nausea
  • anaemia
  • dyspnoea
  • pyrexia
  • injury
  • back pain
  • constipation
  • fatigue
50-59:
  • pain
  • constipation
  • dyspnoea
  • nausea
  • anxiety
  • fatigue
  • asthenia
  • abdominal pain
  • arthralgia
  • fall
60+:
  • pain
  • fall
  • nausea
  • fatigue
  • vomiting
  • asthenia
  • diarrhoea
  • dyspnoea
  • constipation
  • back pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Miralax and Colace?

Can you answer these questions?

More questions for: Miralax, Colace

You may be interested in these reviews

More reviews for: Miralax, Colace

On eHealthMe, Miralax (polyethylene glycol 3350) is often used to treat constipation. Colace (docusate ) is often used to treat constipation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.